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Abstract: Since the spontaneous alteration of native melanotic (Ma) into amelanotic (Ab) transplantable melanoma line it has
been observed that this alteration is accompanied by the acceleration of growth of Ab line. The aim of the present study was
to check and estimate spontaneous apoptosis of cells from cell cycle phases. Cytometric cell cycle analysis was performed by
staining cells with propidium iodide (PI). Apoptosis estimated by the TUNEL method, alterations in the plasma membrane
structure (annexin V staining), changes in the mitochondrial transmembrane potential - ΔΨm (JC-1 staining) showed that
amelanotic melanoma cells have decreased ability to undergo spontaneous apoptosis. The obtained results showing that in the
native melanotic line about 30% of cells are in S+G2/M phases and that 33% of these cells undergo apoptosis could lead to
the conclusion that the slower growth of this melanoma line is the result of lower proliferation activity and higher rate of
apoptosis of these tumor cells. The number of cells in S+G2/M phases in amelanotic melanoma line increases up to 40% and
only 7% of them undergo apoptosis. This observation seems to suggest that the expansive growth of this melanoma line depends
mainly on the decreased ability to undergo spontaneous apoptosis, especially in case of cells from S+G2/M phases. Moreover,
the obtained results indicate that alteration of melanotic line into amelanotic one, accompanied by differences in many
biological features also concerns basic cell processes such as cell cycle and cell death. (www.cm-uj.krakow.pl/FHC)
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Introduction
Research on tumor development seems to indicate that
the growth of tumor depends on cell proliferation and
death, especially by programmed cell death - apoptosis
[10, 11].
It is well known that tumor cells show higher ability
to proliferate because of e.g. autocrine production of
growth factors, higher expression of growth factor re-
ceptors and changes in the signaling pathways that are
involved in the transduction of mitogenic stimuli into the
cell [11, 41].
For over thirty years it has been known that different
tumor cells [26], among them also melanoma [43] die
by apoptosis, which has been considered the reason for
the lower growth rate of some tumors [26]. However,
investigations on the role of apoptosis in chemo-and
radiotherapy [2, 48], clearly showed that tumor cells,
also melanoma cells, have a decreased ability to undergo
apoptosis [37, 42]. The molecular basis of this ability is
far from being understood, despite growing evidence of
the disturbances in the mechanism of melanoma cells
apoptosis [18, 23, 46]. The decreased ability to undergo
apoptosis and the cell cycle disturbances in different
tumor cells are considered to be factors involved in
tumor progression [11, 21]. 
In spite of growing evidence of links between apop-
tosis and cell cycle [15, 33, 50], the nature of these
relationships have not been explained so far.
Our earlier comparative studies of two hamsters
transplantable melanoma lines: melanotic (Ma) and
amelanotic (Ab), except differences in the ultrastructure,
changes in the plasma membrane glycoproteins and
activity of some enzymes, showed also higher growth
rate accompanied by the spontaneous alteration of me-
lanotic melanoma line into amelanotic one [6, 8]. Our
latest investigations [29, 30] indicated that the decreased
ability to undergo apoptosis could favor the higher
growth rate of the amelanotic melanoma.
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In spite of popular opinion that tumor growth depends
not only on the dynamics of tumor clone cell proliferation
but also on the ability of cells to die - especially by
apoptosis [10], it is still not clear which of these phenomena
predominates and decides for the individual tumor growth
[17, 20, 25, 34]. We also do not know in what phases of
cell cycle tumor cells die most easily. 
The problems mentioned above also concern mela-
noma, where clear correlation between proliferation,
apoptosis and tumor progression has not been found [44,
49]. On the other hand, the number of proliferating cells
in melanoma is proposed to be a prognostic marker of
patient’s survival time [1]. 
Therefore, we were especially interested in checking
to what extent the spontaneous alteration of melanotic
line into amelanotic one - with higher growth rate and
shorter animal survival - depends on the ability of cells
in different cell cycle phases to undergo spontaneous
apoptosis, especially in S+G2/M phases which can be
used as indirect measure of proliferative activity of cells
[3, 4, 9]. 
Materials and methods
Animals. 3-4 months old male Syrian (golden) hamsters Mesocrice-
tus auratus Waterhouse, were purchased from the Central Animal
Facilities of the Silesian Medical University, Katowice, Poland. The
experimental procedures were approved by the Animal Ethics Com-
mittee at Medical University of Gdan´sk and conformed to the Na-
tional Health and Medical Research Council’s guide for the care and
use of laboratory animals.
Transplantable melanomas. The melanotic melanoma line (Ma)
was derived from a melanoma of the skin which had appeared
spontaneously in a breed of golden hamsters in 1959 [6]. The
amelanotic melanoma line (Ab) differing in many biological proper-
ties [6,8,27] originated from the melanotic form by a spontaneous
alteration. Melanoma cells were isolated from solid tumors by a
non-enzymatic method [7]. The suspension contained 95-98% of
viable cells (estimated by trypan blue exclusion test). Cells after
isolation were cultured for 4 hours in culture medium (RPMI, 10%
FBS Gibco, antibiotics) [45].
Cell cycle analysis. Ethanol-fixed 1×106 melanoma cells were re-
suspended in 1 ml of staining solution (RNaseA 200 μg/ml and PI -
propidium iodide, 5 μg/ml in PBS) [13]. Then cells were incubated
for 30 min at 37˚C in the dark and the fluorescence was analyzed
using a FACS Calibur flow cytometer (Becton Dickinson Immuno-
cytometry Systems, San Jose, CA, USA; Department of Pathophysio-
logy of Medical University, Gdan´sk). Control diploid cells were cells
isolated from hamster spleens. 10000-20000 events were stored from
each stained sample and analyzed off-line using WinMDI2.6 soft-
ware (obtained from J. Trotter, The Scripps Institute, La Jolla, CA,
USA). Cells in S and G2/M phases of cell cycle were analyzed
together and used as an indirect measure of proliferative activity of
cells [3,4,9].
Estimation of apoptosis by the TUNEL method. The APO-BRDU
Kit (BD Bioscience Pharmingen) was used to determine apoptotic
cells and cell cycle phases they come from. Cells were prepared
following the manufacturer’s protocol. Bivariate analysis of apop-
tosis (green fluorescence) and DNA content (PI) was performed
using the flow cytometer.
Estimation of apoptosis by annexin V staining. Changes in plasma
membrane structure - externalization of phosphatidyl serine - were
assessed by staining cells with Annexin V and PI (Annexin V-Fluos
staining kit, Roche) according to manufacturer’s instructions.
Among annexin-positive cells, we distinguished populations with
low and high level of annexin binding (AnLO and AnHI, respectively).
In association with various levels of staining with PI, the above
allowed us to distinguish three populations of melanoma cells: (1)
fully viable cells - low annexin binding and no PI incorporation
(AnLO ,PI-), (2) viable, early apoptotic cells - high annexin binding
and no PI staining (AnHI,PI-), and (3) necrotic or late apoptotic cells
- high annexin binding and strong PI staining (AnHI,PI+).
Estimation of changes in transmembrane mitochondrial poten-
tial (ΔΨm). Changes of the ΔΨm were analyzed using 5,5’,6 ,6’-te-
trachloro-1,1’3,3’-tetraethylbenzimidazolecarbocyanine iodide
(JC-1; Molecular Probes, Inc.,Eugene, OR, USA). This assay detects
changes in the integrity of the mitochondrial membrane, an early
event in apoptosis [39]. Depending on the ΔΨm JC-1 forms mono-
mers (green fluorescence, low ΔΨm) or aggregates (red fluores-
cence, high ΔΨm) [39]. 1×106 cells/ml were incubated in PBS for 30
min at 37˚C with 10 μg/ml JC-1, washed twice with PBS and
suspended at total volume of 500 μl.
Cells stained for TUNEL, annexin V and with JC-1 were analyzed
using FACS Calibur flow cytometer (Becton Dickinson Immunocy-
tometry Systems, San Jose, CA, USA). After gating out small-sized
(e.g. noncellular debris) objects, 20 000 events were collected for
each experiment. Results were analyzed off-line using WinMDI 2.6
software (obtained from J. Trotter, The Scripps Institute, La Jolla,
CA).
Analysis of apoptosis by detection of DNA fragmentation (lad-
dering). DNA fragmentation was detected according to Bertrand et
al. [5]. DNA from 2×106 cells was isolated and RNA removed by 2
mg/ml RNAse treatment (RNase A, Sigma-Aldrich, USA). Ethanol-
precipitated DNA was dissolved in TE buffer (10 mM Tris, 1 mM
EDTA, pH 7.4), resolved on 1.8% agarose gel and visualized by
staining with ethidium bromide (0.5 μl/ml).
Statistical evaluation. Group data expressed as mean ± S.D. were
statistically estimated by nonparametric Mann-Whitney’s U-test.




The cytometric analysis of cell cycle showed that cells
from S and G2/M phases accounted for about 30% of the
melanotic melanoma cells and their number was signi-
ficantly (p<0.05) lower in comparison to less differen-
tiated, but faster growing amelanotic melanoma, where
almost 40% of cells were in S and G2/M phases (Table
1, Fig. 1A). About 47% of cells, in slowly growing and
more differentiated melanotic melanoma were in G0/G1
phases. Among amelanotic melanoma about 54% of
cells were at that stage of cell cycle (Table 1).
In the histograms of cytometric analysis of DNA
content there were also cells with lower DNA content -
located below G0/G1 (<G0/G1), they included apoptotic
cells (apoptotic bodies). In melanotic melanoma, about
23% of cells were located at sub G1 level but in amela-
notic line only 6% (Fig. 1A).
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Results of the TUNEL method showed that 21% of
melanotic and only 11% of amelanotic melanoma cells
were apoptotic and this difference was statistically sig-
nificant (Table 2, p<0.05). 
The apoptotic cells in both melanoma lines came from
G0/G1 and S+G2/M phases. Among apoptotic melanotic
melanoma cells, about 7% came from G0/G1 phase and
about 10% from S+G2/M phases. In the amelanotic mela-
noma line, apoptotic cells from the abovementioned phases
constituted 2% and almost 3%, respectively (Table 2). The
comparison of these percentages to the proportion of cells
from the particular cell cycle phases in each melanoma line
reveal that in melanotic melanoma 32% of cells in S+G2/M
phases and 15% of cells in G0/G1 underwent apoptosis,
but among amelanotic cells these values were only about
7% and 4% (Table 1).
Binding of annexin V to cells of transplantable me-
lanoma lines showed higher content of cells with phos-
phatidylserine externalization among cells of the native
line, where about 37% cells belonged to the early apop-
totic population AnHIPI-. This proportion was signifi-
cantly (p<0.001) higher than in the amelanotic
melanoma line, where only 3% of cells expressed that
phenotype (Fig. 1B, Table 2). As compared to amela-
notic line, suspensions of melanotic melanoma cells typi-
cally contained also more necrotic cells. On the average,
24% of melanotic melanoma cells and only 13% of
amelanotic melanoma cells were AnHIPI+ (Fig. 1B, Table
2). Analysis of nucleosomal DNA fragmentation (ladde-
ring) showed a typical DNA ladder in the preparations of
melanotic melanoma cell DNA, while DNA fragmentation
in amelanotic melanoma line was very weak (Fig. 1B).
Spontaneous apoptosis of both melanoma line cells
was accompanied by the decrease in mitochondrial
transmembrane potential (ΔΨm), which was observed
in about 6% of the native melanoma line and only in
2.5% of amelanotic cells (this difference was statisti-
cally significant p<0.05, Table 2, Fig. 1B) and sugges-
ting that mitochondria participate in the spontaneous
apoptosis especially in cells of the native line. Decrease
in ΔΨm is an early event in apoptosis and this seemed
to be confirmed in cells of amelanotic melanoma line
where we found 2.5% of cells with decreased ΔΨm and
3.4% of cells with changed plasma membrane structure.
Among cells of melanotic melanoma line, 6% had de-
creased ΔΨm, while 37% externalized PS (Table 2).
Discussion
Our results indicating that melanotic melanoma line,
growing slowly, more differentiated, has lower content
of cells in S+G2/M phases in comparison to faster grow-
ing, less differentiated amelanotic melanoma line are in
agreement with authors showing that tumor growth de-
pends on the content of proliferating cells [29] and the
Table 1. Cell cycle analysis and the ability to unergo spontaneous apoptosis of melanotic (Ma) and amelanotic (Ab) transplantable melanoma
cells estimated by the TUNEL method 
Melanoma cells
Cell cycle analysis Spontaneous apoptosis Cells dying by apoptosis 
% of cells in total % of
apoptotic cells
% of apoptotic cells from
G0/G1 S + G2/M
G0/G1 S and G2/M G0/G1 S + G2/M
melanotic (Ma) 47.1 ± 4.2 30.1 ± 4.2 21.1 ± 5.3 7.0 ± 2.0 9.5 ± 4.3 15% 32%
amelanotic (Ab) 54.3 ± 4.7  38.9 ± 5.3*  11.3 ± 3.1*  2.3 ± 0.4*  2.7 ± 0.4*  4%  7%
The values are the means ± SD of 5 and 6 experiments for Ma and Ab melanoma lines, respectively; *statistically significant 0.05>p>0.001
Table 2. The ability to undergo spontaneous apoptosis (estimated by: changes in the plasma membrane structure - externalization of
phosphatidylserine, changes in the transmembrane mitochondrial potential- ΔΨm and TUNEL method) of melanotic (Ma) and amelanotic
(Ab) transplantable melanoma cells.
Melanoma cells
Spontaneous apoptosis
Changes in the plasma membrane
% of cells with
decreased  ΔΨm
% of apoptotic cells  (TUNEL method)









melanotic (Ma) 36.9 ± 5.7 23.9 ± 4.1 5.7 ± 2.2 21.1 ± 5.3 7.0 ± 2.0 9.5 ± 4.3
amelanotic (Ab)   3.4 ± 1.0*  12.7 ± 3.9*  2.5 ± 1.0*  11.3 ± 3.1*  2.3 ± 0.4*  2.7 ± 0.6*
AnHI/PI-: viable, early apoptotic cells - high annexin binding and no PI staining;  AnHI/PI+: necrotic or late apoptotic cells - high annexin
binding and strong PI staining. The values are the means ± SD of: 12-14 experiments for estimation of changes in the plasma membrane, 4-7
experiments for estimation of changes in ΔΨm, 5-6 experiments for TUNEL method; *statistically significant 0.05>p>0.001
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Fig. 1. Histograms of cell cycle analysis (A) and DNA fragmentation, changes in the transmembrane mitochondrial potential (ΔΨm) and in
the plasma membrane structure (externalization of phosphatidylserine - PS) in spontaneous apoptosis (B) of melanotic (Ma) and amelanotic
(Ab) melanoma cells. One of representative experiments.
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growth rate is higher in less differentiated tumors [20,
34]. The higher proliferative activity of amelanotic me-
lanoma cells reflects more aggressive phenotype in com-
parison to melanotic melanoma line, as observed also by
others in human melanoma cells [3, 31].
The estimation of apoptotic cells by the TUNEL
method indicates that melanotic melanoma cells have
statistically higher ability to undergo programmed cell
death in comparison to amelanotic ones. This was con-
firmed by our present results demonstrating decrease in
ΔΨm, changes in the plasma membrane structure and
endonucleosomal DNA degradation (apoptotic ladder).
The phosphatidylserine externalization and apop-
totic DNA fragmentation were more pronounced in cells
from melanotic melanoma line than in the amelanotic
one - growing faster. In amelanotic melanoma line, the
percentage of cells with changed plasma membrane
structure corresponds to the percentage of cells with
decreased ΔΨm. The higher percentage of cells with
changes in the plasma membrane among cells of mela-
notic melanoma line, in comparison to cells with de-
creased ΔΨm, could reflect not only apoptotic changes
in the plasma membrane structure [47, 51]. 
In the native melanoma line, apoptotic cells came
mainly from S+G2/M phases whereas in the amelanotic
one similar proportions of all cell cycle phases were ob-
served among apoptotic cells. Thus, above-mentioned re-
sults confirm our earlier suppositions, that cells of
amelanotic melanoma line apart from the higher propor-
tion of cells in S/G2/M phases have also decreased ability
to undergo spontaneous apoptosis in all cell cycle phases.
We can not discuss our observation with those of
other authors because we could not find any information
in the literature from which cell cycle phases come
melanoma cells undergoing spontaneous apoptosis. 
The mechanism responsible for the decreased ability
to undergo spontaneous apoptosis in transplantable ame-
lanotic melanoma cells is difficult to explain so far.
Some reports have indicated that melanoma cells show
changes in the expression of antiapoptotic proteins from
Bcl-2 and IAP (inhibitors of apoptosis proteins) families
[19, 22, 40]. Among IAP proteins, a special role of
survivin is stressed because of its involvement in cell
proliferation [18]. 
Recently, a few studies showed that the expression
of P-glycoprotein in neoplastic cells showed an antia-
poptotic effect [24, 38]. This observation is in agreement
with our earlier results [28], demonstrating higher P-gly-
coprotein expression in amelanotic melanoma cells -
which have decreased ability to undergo apoptosis.
The results of other authors concerning the relation-
ships between tumor growth and the ability of its cells
to proliferate and undergo apoptosis are controversial;
some authors showed that tumor growth depends mainly
on cell proliferation [34], others indicated that both
proliferation and apoptosis increases [17, 25], or that
higher proliferation with decreased ability to undergo
apoptosis support tumor progression [20, 25].
Observations of others that human melanoma cells
have very low ability to undergo spontaneous apoptosis
[22, 35, 41] and proliferating cells accounted for 20-40%
of all cells [32, 36, 49] led them to the conclusion that
the growth of human melanoma depends mainly on cell
proliferative activity [35, 44]. 
In contrast, our present results may suggest that the
expansive growth of the amelanotic melanoma line de-
pends mainly on the decreased ability of cells in all cell
cycle phases to undergo spontaneous apoptosis. Accord-
ing to the latest reports it seems that cell cycle regulation
is an individual feature of each tumor type [12, 14, 16],
similarly to the ability to undergo spontaneous apoptosis
[37], which is in agreement with our present observa-
tions. 
If decreased ability of cells to undergo spontaneous
apoptosis also appears in human melanoma progression
and in different melanoma lines not examined so far,
such observation could be helpful in the therapy. 
Finally, the obtained results indicate that alteration of
melanotic line into amelanotic one, accompanied by
changes in many biological features also concerns such
fundamental cell processes as cell cycle and cell death.
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